{"id":3180,"date":"2015-12-14T19:17:25","date_gmt":"2015-12-14T19:17:25","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=4993"},"modified":"2015-12-14T19:17:25","modified_gmt":"2015-12-14T19:17:25","slug":"medical-marijuana-inc-s-hempmeds-brasil-now-has-three-medical-indications-approved-as-prescriptions-100-of-the-costs-now-covered-by-brazilian-government","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2015\/12\/14\/medical-marijuana-inc-s-hempmeds-brasil-now-has-three-medical-indications-approved-as-prescriptions-100-of-the-costs-now-covered-by-brazilian-government\/","title":{"rendered":"Medical Marijuana, Inc.\u2019s HempMeds Brasil\u2122 Now Has Three Medical Indications Approved As Prescriptions \u2013 100% of the Costs Now Covered by Brazilian Government"},"content":{"rendered":"

Medical Marijuana, Inc.\u2019s Hemp-Based Cannabidiol (CBD) Oil Products Cost Being 100% Subsidized by the Brazilian Government for Three Indications: Epilepsy, Parkinson\u2019s and Chronic Pain<\/em><\/h2>\n

San Diego, Calif. — December 14, 2015 <\/strong>\u2013 Medical Marijuana, Inc.<\/a>\u2019s (OTC Pink: MJNA) cannabidiol (CBD) hemp oil<\/a> \u2013 a legal U.S. cannabis product shipping to all 50 states \u2013 is creating global demand and a new business category for export. HempMeds Brasil\u2122<\/a> has developed a portfolio of nine products for export into the Latin American prescription drug markets, of which three indications are approved and the full cost paid by the Brazilian Government.<\/p>\n

To date, for HempMeds Brasil\u2122<\/a> the three indications<\/em> approved for export from the U.S. to Brazil are: epilepsy<\/a>, Parkinson\u2019s disease<\/a> and chronic pain<\/a>, with several more serious health conditions expected to be added over the coming quarter. Currently, Brazil is the world\u2019s 7<\/a>th<\/sup><\/a>–<\/a>largest economy<\/a>, as well as the largest national economy in Latin America \u2013 and has a population of more than 204 million<\/a> people.<\/p>\n

Across the globe, these indications affect billions of people:<\/p>\n